nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—brown adipose tissue—hypothyroidism	0.148	0.21	CbGeAlD
Etomidate—CYP19A1—corpus luteum—hypothyroidism	0.0907	0.128	CbGeAlD
Etomidate—CYP19A1—seminiferous tubule of testis—hypothyroidism	0.0769	0.109	CbGeAlD
Etomidate—SLC2A1—heart—hypothyroidism	0.024	0.034	CbGeAlD
Etomidate—SLC2A1—cardiovascular system—hypothyroidism	0.0227	0.0321	CbGeAlD
Etomidate—CYP11B1—adrenal cortex—hypothyroidism	0.0213	0.0301	CbGeAlD
Etomidate—CYP11B2—adrenal cortex—hypothyroidism	0.0213	0.0301	CbGeAlD
Etomidate—SLC2A1—gonad—hypothyroidism	0.0206	0.0291	CbGeAlD
Etomidate—CYP11B2—heart—hypothyroidism	0.0206	0.0291	CbGeAlD
Etomidate—CYP11B2—cardiovascular system—hypothyroidism	0.0194	0.0275	CbGeAlD
Etomidate—SLC2A1—adrenal gland—hypothyroidism	0.0179	0.0254	CbGeAlD
Etomidate—SLC2A1—blood—hypothyroidism	0.0179	0.0254	CbGeAlD
Etomidate—SLC2A1—thyroid gland—hypothyroidism	0.0173	0.0245	CbGeAlD
Etomidate—SLC2A1—female gonad—hypothyroidism	0.0167	0.0237	CbGeAlD
Etomidate—CYP11B1—adrenal gland—hypothyroidism	0.0154	0.0218	CbGeAlD
Etomidate—CYP11B2—adrenal gland—hypothyroidism	0.0154	0.0218	CbGeAlD
Etomidate—CYP11B1—blood—hypothyroidism	0.0154	0.0217	CbGeAlD
Etomidate—CYP11B2—blood—hypothyroidism	0.0154	0.0217	CbGeAlD
Etomidate—SLC2A1—testis—hypothyroidism	0.0148	0.021	CbGeAlD
Etomidate—SLC2A1—liver—hypothyroidism	0.014	0.0199	CbGeAlD
Etomidate—SLC2A1—cerebellum—hypothyroidism	0.0137	0.0194	CbGeAlD
Etomidate—CYP11B2—Glucocorticoid biosynthesis—POMC—hypothyroidism	0.0133	0.0679	CbGpPWpGaD
Etomidate—Arrhythmia—Liothyronine—hypothyroidism	0.0121	0.123	CcSEcCtD
Etomidate—SLC2A1—NRF2 pathway—SLC5A7—hypothyroidism	0.0119	0.0608	CbGpPWpGaD
Etomidate—CYP11B1—Glucocorticoid biosynthesis—POMC—hypothyroidism	0.0114	0.0585	CbGpPWpGaD
Etomidate—Hypertension—Liothyronine—hypothyroidism	0.0101	0.103	CcSEcCtD
Etomidate—Tachycardia—Liothyronine—hypothyroidism	0.00936	0.0954	CcSEcCtD
Etomidate—Hypotension—Liothyronine—hypothyroidism	0.00896	0.0914	CcSEcCtD
Etomidate—GABRG2—pituitary gland—hypothyroidism	0.00783	0.0111	CbGeAlD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00749	0.0383	CbGpPWpGaD
Etomidate—CYP19A1—gonad—hypothyroidism	0.00651	0.00922	CbGeAlD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00621	0.0317	CbGpPWpGaD
Etomidate—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00592	0.0604	CcSEcCtD
Etomidate—Arrhythmia—Levothyroxine—hypothyroidism	0.00592	0.0604	CcSEcCtD
Etomidate—GABRB2—testis—hypothyroidism	0.00579	0.00819	CbGeAlD
Etomidate—CYP11B2—Endogenous sterols—POMC—hypothyroidism	0.0057	0.0292	CbGpPWpGaD
Etomidate—CYP19A1—adrenal gland—hypothyroidism	0.00567	0.00803	CbGeAlD
Etomidate—CYP19A1—blood—hypothyroidism	0.00567	0.00803	CbGeAlD
Etomidate—CYP19A1—thyroid gland—hypothyroidism	0.00548	0.00775	CbGeAlD
Etomidate—GABRB2—cerebellum—hypothyroidism	0.00535	0.00757	CbGeAlD
Etomidate—GABRG2—cerebellum—hypothyroidism	0.00535	0.00757	CbGeAlD
Etomidate—CYP19A1—female gonad—hypothyroidism	0.00529	0.00749	CbGeAlD
Etomidate—SLC2A1—Insulin Signaling—PIK3C2A—hypothyroidism	0.00526	0.0269	CbGpPWpGaD
Etomidate—Convulsion—Levothyroxine—hypothyroidism	0.005	0.051	CcSEcCtD
Etomidate—Convulsion—Dextrothyroxine—hypothyroidism	0.005	0.051	CcSEcCtD
Etomidate—CYP11B1—Endogenous sterols—POMC—hypothyroidism	0.00491	0.0251	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—SLC5A5—hypothyroidism	0.00475	0.0243	CbGpPWpGaD
Etomidate—GABRA1—cerebellum—hypothyroidism	0.00472	0.00668	CbGeAlD
Etomidate—CYP19A1—testis—hypothyroidism	0.00469	0.00664	CbGeAlD
Etomidate—Tachycardia—Levothyroxine—hypothyroidism	0.0046	0.0469	CcSEcCtD
Etomidate—Tachycardia—Dextrothyroxine—hypothyroidism	0.0046	0.0469	CcSEcCtD
Etomidate—CYP19A1—liver—hypothyroidism	0.00444	0.00628	CbGeAlD
Etomidate—Arrhythmia—Liotrix—hypothyroidism	0.00436	0.0444	CcSEcCtD
Etomidate—CYP11B2—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00427	0.0218	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00381	0.0195	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00368	0.0188	CbGpPWpGaD
Etomidate—Convulsion—Liotrix—hypothyroidism	0.00368	0.0375	CcSEcCtD
Etomidate—Hypertension—Liotrix—hypothyroidism	0.00367	0.0374	CcSEcCtD
Etomidate—Tachycardia—Liotrix—hypothyroidism	0.00338	0.0345	CcSEcCtD
Etomidate—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00333	0.0171	CbGpPWpGaD
Etomidate—Hypotension—Liotrix—hypothyroidism	0.00324	0.033	CcSEcCtD
Etomidate—SLC2A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00315	0.0161	CbGpPWpGaD
Etomidate—Vomiting—Dextrothyroxine—hypothyroidism	0.003	0.0305	CcSEcCtD
Etomidate—Vomiting—Levothyroxine—hypothyroidism	0.003	0.0305	CcSEcCtD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00299	0.0153	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00279	0.0143	CbGpPWpGaD
Etomidate—CYP19A1—Endogenous sterols—POMC—hypothyroidism	0.00278	0.0142	CbGpPWpGaD
Etomidate—CYP11B2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00265	0.0135	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—IYD—hypothyroidism	0.00257	0.0132	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00255	0.013	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00239	0.0122	CbGpPWpGaD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.00236	0.0121	CbGpPWpGaD
Etomidate—CYP11B1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00228	0.0117	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00223	0.0114	CbGpPWpGaD
Etomidate—Vomiting—Liotrix—hypothyroidism	0.0022	0.0225	CcSEcCtD
Etomidate—SLC2A1—Metabolism—ATP5O—hypothyroidism	0.00219	0.0112	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00219	0.0112	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00215	0.011	CbGpPWpGaD
Etomidate—CYP11B2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00215	0.011	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.00214	0.0109	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00209	0.0107	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TPO—hypothyroidism	0.00206	0.0105	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.00195	0.00999	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00191	0.00977	CbGpPWpGaD
Etomidate—CYP11B1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00185	0.00946	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.0018	0.00919	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.00171	0.00873	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00164	0.0084	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—POMC—hypothyroidism	0.00162	0.00829	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00152	0.00778	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00144	0.00735	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—NEFL—hypothyroidism	0.00138	0.00704	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—IYD—hypothyroidism	0.00134	0.00688	CbGpPWpGaD
Etomidate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00129	0.00661	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—NEFL—hypothyroidism	0.00126	0.00644	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.0012	0.00613	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—IYD—hypothyroidism	0.00116	0.00593	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00115	0.00587	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ATP5O—hypothyroidism	0.00114	0.00585	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—POMC—hypothyroidism	0.00114	0.00583	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—NEFL—hypothyroidism	0.0011	0.00563	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TPO—hypothyroidism	0.00108	0.0055	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00105	0.00537	CbGpPWpGaD
Etomidate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00105	0.00536	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000996	0.0051	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ATP5O—hypothyroidism	0.000985	0.00504	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—POMC—hypothyroidism	0.000982	0.00503	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TSHB—hypothyroidism	0.000952	0.00487	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000951	0.00487	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TPO—hypothyroidism	0.000927	0.00474	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000918	0.0047	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000892	0.00456	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00087	0.00445	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000858	0.00439	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000855	0.00438	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3C2A—hypothyroidism	0.000848	0.00434	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000795	0.00407	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000795	0.00407	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000761	0.00389	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PRL—hypothyroidism	0.000751	0.00384	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—SLC5A5—hypothyroidism	0.000712	0.00364	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—TRH—hypothyroidism	0.000679	0.00347	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—IYD—hypothyroidism	0.000657	0.00336	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000642	0.00329	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—TSHR—hypothyroidism	0.000605	0.0031	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—TSHB—hypothyroidism	0.000605	0.0031	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ATP5O—hypothyroidism	0.000558	0.00286	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—POMC—hypothyroidism	0.000557	0.00285	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TPO—hypothyroidism	0.000525	0.00269	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TSHB—hypothyroidism	0.000498	0.00255	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000486	0.00249	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SH2B3—hypothyroidism	0.000482	0.00247	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000468	0.0024	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000459	0.00235	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3C2A—hypothyroidism	0.000444	0.00227	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000438	0.00224	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TSHB—hypothyroidism	0.000429	0.00219	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00042	0.00215	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000396	0.00202	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—POMC—hypothyroidism	0.000392	0.002	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—TRH—hypothyroidism	0.000384	0.00196	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3C2A—hypothyroidism	0.000382	0.00196	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000377	0.00193	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—POMC—hypothyroidism	0.000373	0.00191	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SLC5A5—hypothyroidism	0.000373	0.00191	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000367	0.00188	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000361	0.00185	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—AVP—hypothyroidism	0.000357	0.00183	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TRH—hypothyroidism	0.000349	0.00178	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—TSHB—hypothyroidism	0.000342	0.00175	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—TSHR—hypothyroidism	0.000342	0.00175	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VAV3—hypothyroidism	0.000331	0.00169	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00033	0.00169	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SLC5A5—hypothyroidism	0.000321	0.00164	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000311	0.00159	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TSHB—hypothyroidism	0.000311	0.00159	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TSHR—hypothyroidism	0.000311	0.00159	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000289	0.00148	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TSHB—hypothyroidism	0.000243	0.00124	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	0.000238	0.00122	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	0.000237	0.00121	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3C2A—hypothyroidism	0.000217	0.00111	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000214	0.00109	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000209	0.00107	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TRH—hypothyroidism	0.000206	0.00105	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF1—hypothyroidism	0.000204	0.00104	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	0.000202	0.00103	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—POMC—hypothyroidism	0.000195	0.000997	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	0.00019	0.000972	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	0.000184	0.000939	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	0.000184	0.000939	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	0.000183	0.000937	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC5A5—hypothyroidism	0.000182	0.000931	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—POMC—hypothyroidism	0.000168	0.000859	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	0.000164	0.000837	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	0.000134	0.000685	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	0.000122	0.000622	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRL—hypothyroidism	0.000121	0.000621	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	0.000112	0.000574	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AVP—hypothyroidism	0.000108	0.000553	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—POMC—hypothyroidism	9.52e-05	0.000487	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—POMC—hypothyroidism	7.19e-05	0.000368	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	6.91e-05	0.000354	CbGpPWpGaD
